Literature DB >> 402961

Blood viscosity in Waldenström macroglobulinemia.

M R MacKenzie, T K Lee.   

Abstract

Patients with Waldenström macroglobulinemia were studied for the presence or absence of the hyperviscosity syndrome, the relative serum viscosity value, and the calculated whole blood viscosity to identify a level at which symptoms occurred. The majority of symptomatic patients had whole blood viscosity values above 8.0 centipoises. There was a direct correlation between whole blood viscosity and relative serum viscosity, r = 0.75. One patient with central nervous system abnormalities was identified as having a high whole blood viscosity but a low serum viscosity. It was concluded that the vast majority of patients with the hyperviscosity syndrome will be identified by measuring the relative serum viscosity. In patients with central nervous system findings and a low serum viscosity, the whole blood viscosity should be determined either by direct measurement or by calculation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402961

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Pulmonary vascular resistance and viscosity: the forgotten factor.

Authors:  Julien I E Hoffman
Journal:  Pediatr Cardiol       Date:  2011-03-25       Impact factor: 1.655

2.  Waldenstrom's macroglobulinemia, a hyperviscosity manifestation of venous stasis retinopathy.

Authors:  S S Feman; R S Stein
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

Review 3.  Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices.

Authors:  Jamie O Musick; Kirby S Fibben; Wilbur A Lam
Journal:  Curr Opin Hematol       Date:  2022-07-18       Impact factor: 3.218

4.  In silico biophysics and hemorheology of blood hyperviscosity syndrome.

Authors:  Elahe Javadi; Yixiang Deng; George Em Karniadakis; Safa Jamali
Journal:  Biophys J       Date:  2021-06-02       Impact factor: 3.699

5.  Exertional Chest Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal Zone Lymphoma.

Authors:  Prajwal Dhakal; Vijaya Raj Bhatt; Smrity Upadhyay; Nabin Khanal; Apar Kishor Ganti
Journal:  World J Oncol       Date:  2014-08-25

6.  Targeted IgMs agonize ocular targets with extended vitreal exposure.

Authors:  Yvonne Chen; Maciej Paluch; Julie A Zorn; Sharmila Rajan; Brandon Leonard; Alberto Estevez; John Brady; Henry Chiu; Wilson Phung; Amin Famili; Minhong Yan; Claudio Ciferri; Marissa L Matsumoto; Greg A Lazar; Susan Crowell; Phil Hass; Nicholas J Agard
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.